Key points A 47-year-old French-speaking woman of African descent presented to the emergency department with a 1-week history of severe foot pain and difficulty walking. For the preceding 2 months she ...
The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 ...
Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...
After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...
Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.
Zenas BioPharma, Inc.'s obexelimab's potential in treating autoimmune diseases and upcoming phase 2 & 3 trial results. Read ...
Lupus Alert Day serves a vital purpose. It encourages others to learn more about lupus, share information on social media, ...
Alumis Inc. focuses on TYK2 inhibitors ESK-001 and A-005, with ESK-001 in Phase 3 for plaque psoriasis. Find out why ALMS ...
In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle ...
Artiva Biotherapeutics, Inc.’s ARTV share price has surged by 31.15%, which has investors questioning if this is right time ...
Inquirer.net - Philippines Entertainment News on MSN5d
Kris Aquino suffers from lupus flare fever, shows visible spine: ‘My now’Kris Aquino revealed her "pain and struggle" amid suffering from lupus flare fever for over two weeks now, appealing to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback